Explore All 297 Growth Capital Consumer Services Deals - Search the Database Free
Investment Summary |
|
|---|---|
| Date | January 1, 2012 |
| Target | Diamondback Drugs |
| Sector | Consumer Services |
| Investor(s) | Sheridan Capital Partners |
| Deal Type | Growth Capital |
FILTER BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2012 |
| PE ASSETS | 300M USD |
| Size | Middle-Market |
| Type | Sector Agnostic |
Sheridan Capital Partners is a private equity firm focused on acquiring and investing in consumer products/services and healthcare companies across the US and Canada. Sheridan looks to invest $15 to $100 million in businesses valued from $25 to $150 million. Prospective transaction situations include growth buyouts, family owned company acquisitions, consolidations, and recapitalizations. Sheridan Capital Partners was formed in 2012 and is headquartered in Chicago, Illinois.
| Deal Context for Investor | # |
|---|---|
| Overall | 1 of 21 |
| Sector: Consumer Services | 1 of 1 |
| Type: Growth Capital | 1 of 13 |
| State: Arizona | 1 of 2 |
| Country: United States | 1 of 20 |
| Year: 2012 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-10-30 |
Progenicare
Austin, Texas, United States Progenicare is a provider of autologous stem cell therapies to orthopedic surgeons and hospitals across the Western U.S. Progenicare was founded in 2008 and is based in Austin, Texas. |
Buy | - |
